Spontaneous Bacterial Peritonitis (SBP) Diagnosis & Treatment — free guideline decision tool
This tool diagnoses and treats spontaneous bacterial peritonitis using ascitic-fluid PMN, acquisition setting, and prior history, with empiric antibiotics, albumin, and prophylaxis.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Ascitic-fluid neutrophils (PMN) | ≥ 250/mm³ (confirms SBP) |
|---|---|
| Acquisition setting | Community-acquired |
| Prior SBP history | Present |
→DispositionEmpiric antibiotics + albumin
- Diagnosis:Ascitic PMN ≥ 250/mm³ (with or without positive culture) diagnoses SBP; all hospitalized cirrhotic ascites or suspected infection should have diagnostic paracentesis, bedside inoculation of ≥ 10 mL ascites into blood-culture bottles plus blood cultures, without waiting for results
- Antibiotics:Community-acquired: third-generation cephalosporin (cefotaxime 2 g q8h, or ceftriaxone) first-line; course usually ≥ 5 days and until ascitic PMN < 250, recheck ascitic PMN at 48 h to assess response (insufficient drop needs adjustment or exclusion of secondary peritonitis)
- Albumin:1.5 g/kg on diagnosis day + 1 g/kg on day 3 (especially creatinine > 1 mg/dL, BUN > 30, or bilirubin > 4), reducing hepatorenal syndrome and mortality
| Ascitic-fluid neutrophils (PMN) | < 250/mm³ |
|---|---|
| Acquisition setting | Nosocomial / recent antibiotics / high resistance risk |
| Prior SBP history | Absent |
→DiagnosisPMN < 250: does not support SBP
- Interpretation:Ascitic neutrophils (PMN) < 250/mm³: does not meet SBP criteria; correlate clinically to seek another infection source, repeat paracentesis if needed
- Caveat:With strong clinical suspicion (fever, abdominal pain/tenderness, encephalopathy, or renal injury), empiric treatment may still be given with ascitic + blood cultures sent; a positive culture with PMN < 250 is monomicrobial non-neutrocytic bacterascites, individualized
- Basis:AASLD/EASL guidelines on cirrhotic ascites and SBP
Common questions
What is Spontaneous Bacterial Peritonitis (SBP) Diagnosis & Treatment?
This tool diagnoses and treats spontaneous bacterial peritonitis using ascitic-fluid PMN, acquisition setting, and prior history, with empiric antibiotics, albumin, and prophylaxis.
How is Spontaneous Bacterial Peritonitis (SBP) Diagnosis & Treatment calculated? What is the core formula?
PMN ≥ 250/mm³ → SBP. Community → cefotaxime/ceftriaxone; nosocomial/high-resistance → broad-spectrum per local resistance. Albumin 1.5 g/kg day 1 + 1 g/kg day 3. Prior history → long-term quinolone prophylaxis.
When is Spontaneous Bacterial Peritonitis (SBP) Diagnosis & Treatment used?
Use to confirm SBP at PMN ≥ 250/mm³, choose empiric antibiotics by setting, add albumin to reduce hepatorenal syndrome, and decide secondary prophylaxis.
What are the key clinical points for Spontaneous Bacterial Peritonitis (SBP) Diagnosis & Treatment?
Albumin alongside antibiotics is most beneficial when creatinine > 1 mg/dL, BUN > 30, or bilirubin > 4, where it reduces hepatorenal syndrome and death. (original synthesis · not guideline verbatim) A 48 h ascitic-PMN recheck assesses response; an insufficient drop prompts adjustment or exclusion of secondary peritonitis. Non-selective β-blockers are stopped in hypotensive or refractory SBP.
What are the limits and cautions when using Spontaneous Bacterial Peritonitis (SBP) Diagnosis & Treatment?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
How is Spontaneous Bacterial Peritonitis (SBP) Diagnosis & Treatment calculated in practice? Can you show a worked example?
Inputs: Ascitic-fluid neutrophils (PMN) ≥ 250/mm³ (confirms SBP), Acquisition setting Community-acquired, Prior SBP history Present → Result: Disposition Empiric antibiotics + albumin(Diagnosis: Ascitic PMN ≥ 250/mm³ (with or without positive culture) diagnoses SBP; all hospitalized cirrhotic ascites or suspected infection should have diagnostic paracentesis, bedside inoculation of ≥ 10 mL ascites into blood-culture bottles plus blood cultures, without waiting for results, Antibiotics: Community-acquired: third-generation cephalosporin (cefotaxime 2 g q8h, or ceftriaxone) first-line; course usually ≥ 5 days and until ascitic PMN < 250, recheck ascitic PMN at 48 h to assess response (insufficient drop needs adjustment or exclusion of secondary peritonitis), Albumin: 1.5 g/kg on diagnosis day + 1 g/kg on day 3 (especially creatinine > 1 mg/dL, BUN > 30, or bilirubin > 4), reducing hepatorenal syndrome and mortality) Inputs: Ascitic-fluid neutrophils (PMN) < 250/mm³, Acquisition setting Nosocomial / recent antibiotics / high resistance risk, Prior SBP history Absent → Result: Diagnosis PMN < 250: does not support SBP(Interpretation: Ascitic neutrophils (PMN) < 250/mm³: does not meet SBP criteria; correlate clinically to seek another infection source, repeat paracentesis if needed, Caveat: With strong clinical suspicion (fever, abdominal pain/tenderness, encephalopathy, or renal injury), empiric treatment may still be given with ascitic + blood cultures sent; a positive culture with PMN < 250 is monomicrobial non-neutrocytic bacterascites, individualized, Basis: AASLD/EASL guidelines on cirrhotic ascites and SBP)
Run Spontaneous Bacterial Peritonitis (SBP) Diagnosis & Treatment now
This tool diagnoses and treats spontaneous bacterial peritonitis using ascitic-fluid PMN, acquisition setting, and prior history, with empiric antibiotics, albumin, and prophylaxis.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.